Detalhe da pesquisa
1.
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397811
2.
Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis.
Platelets
; 30(7): 893-900, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365350
3.
Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems.
J Thromb Haemost
; 21(4): 814-827, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36990522
4.
Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation.
Res Pract Thromb Haemost
; 6(4): e12715, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35647477
5.
Drugs in phase I and II clinical development for the prevention of stroke in patients with atrial fibrillation.
Expert Opin Investig Drugs
; 30(10): 1057-1069, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682570
6.
Observations on clot properties in atrial fibrillation: Relation to renal function and choice of anticoagulant.
Thromb Res
; 197: 69-76, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189061
7.
The role of activated coagulation factor XII in overall clot stability and fibrinolysis.
Thromb Res
; 136(2): 474-80, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26153047
8.
Altered fibrin clot structure in patients with atrial fibrillation and worsening renal function.
Thromb Haemost
; 116(3): 408-9, 2016 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27356648